Related Experiment Videos
The role of apolipoprotein A-I-containing lipoproteins in atherosclerosis
1Life Sciences Division, Lawrence Berkeley Laboratory, Berkeley, California.
Insights
Apolipoprotein A-I (ApoA-I) protects against atherosclerosis by promoting cholesterol removal. However, apolipoprotein A-II (ApoA-II) may counteract these protective effects, complicating the understanding of cardiovascular disease development.
Area of Science:
- Cardiovascular Biology
- Lipid Metabolism
- Atherosclerosis Research
Background:
- The protective role of high-density lipoprotein (HDL) and apolipoprotein A-I (ApoA-I) against premature atherosclerosis is known.
- The precise mechanisms underlying ApoA-I's protective functions remain incompletely understood.
Purpose of the Study:
- To explore the multifaceted roles of apolipoprotein A-I in antiatherogenesis.
- To investigate specific ApoA-I subpopulations and lipid-free ApoA-I in cholesterol efflux.
- To examine the influence of apolipoprotein A-II (ApoA-II) on ApoA-I's protective effects.
Main Methods:
- Analysis of specific apolipoprotein A-I subpopulations.
- Investigation of lipid-free apolipoprotein A-I functions.
- Studies involving transgenic mouse models to assess apolipoprotein A-II interactions.
Main Results:
- Certain apolipoprotein A-I subclasses and lipid-free ApoA-I may enhance cellular cholesterol efflux.
- ApoA-I-containing particles exhibit novel functions in modulating cytokines and lipid hydroperoxide transport.
- Transgenic mouse studies reveal apolipoprotein A-II as a potential antagonist to ApoA-I's atheroprotective properties.
Conclusions:
- Apolipoprotein A-I plays a complex, protective role in preventing atherosclerosis through various mechanisms.
- The interaction between apolipoprotein A-I and apolipoprotein A-II is critical for understanding atherosclerosis development.
- Further research is needed to elucidate the complete antiatherogenic pathways involving ApoA-I and its modulators.
Abstract:
The inverse relationship between HDL and apolipoprotein A-I concentrations and the risk for premature atherosclerosis is well established, but the mechanism whereby apolipoprotein A-I offers protection is still somewhat elusive. Recent studies suggest that a specific subpopulation within the lipoprotein (AI) subclass may be more effective than others in promoting cholesterol efflux from cells. In addition, it appears that the lipid-free form of apolipoprotein A-I may have an important role in the antiatherosclerotic process. Unique new functions of apolipoprotein A-I-containing particles in modulating cytokines and lipid hydroperoxide transport, together with their role in antiatherogenesis, are also discussed. Current research with transgenic mice, however, indicates that apolipoprotein A-II must be taken into consideration in understanding the development of atherosclerosis, because it appears to be a potent antagonist for the protective properties of apolipoprotein A-I.